Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr., Baltimore, MD 21224, USA.
Drug Alcohol Depend. 2020 Mar 1;208:107772. doi: 10.1016/j.drugalcdep.2019.107772. Epub 2020 Jan 20.
Ecstasy typically contains adulterants in addition to, or in lieu of, MDMA which may pose a greater risk to users than MDMA itself. The current study aimed to evaluate the effectiveness of adulterant-related informational prompts in reducing Ecstasy use using a novel probability discounting task.
An online sample of past-month Ecstasy users (N = 278) were randomized to one of four different framing prompt conditions: no prompt; a prompt describing MDMA's effects; a prompt describing adulterants as inert "filler"; or a prompt describing adulterants as pharmacologically-active, potentially-harmful compounds. Each prompt contained general, potential public-health information that was not specifically related to subsequent behavioral tasks. All participants then completed an identical Drug Purity Discounting Task, in which they indicated the likelihood of using a sample of Ecstasy across different probabilities of the sample being impure, and then completed a hypothetical Ecstasy purchasing task.
Likelihood of Ecstasy use decreased as impurity probability increased across conditions. Ecstasy use likelihood was highest in the "inert" prompt condition, whereas pharmacologically-active adulterant or adulterant-nonspecific prompts resulted in comparably low likelihood of use. Ecstasy-use likelihood did not differ among conditions when the likelihood of sample impurity was 0. Ecstasy purchasing did not differ among groups. Inelastic purchasing was associated with greater likelihood of using potentially-impure Ecstasy.
Altogether, these data highlight the necessity of education regarding pharmacologically-active, rather than inert, adulterants in Ecstasy, and suggest that increased access to drug checking kits and services may mitigate some of the harms associated with Ecstasy use.
摇头丸通常除了 MDMA 之外还含有掺杂物,或者用 MDMA 代替,这可能比 MDMA 本身对使用者构成更大的风险。本研究旨在使用一种新颖的概率折扣任务评估与掺杂物相关的信息提示对减少摇头丸使用的有效性。
过去一个月使用摇头丸的在线样本(N=278)被随机分配到以下四种不同的提示条件之一:无提示;描述 MDMA 效果的提示;将掺杂物描述为惰性“填充物”的提示;或描述掺杂物为药理活性、潜在有害化合物的提示。每个提示都包含一般的、潜在的公共卫生信息,与随后的行为任务无关。所有参与者随后都完成了相同的毒品纯度折扣任务,在该任务中,他们表示在样本不纯的不同概率下使用样本摇头丸的可能性,然后完成了一个假设的摇头丸购买任务。
在所有条件下,随着不纯概率的增加,摇头丸使用的可能性降低。在“惰性”提示条件下,摇头丸使用的可能性最高,而药理活性掺杂物或掺杂物非特异性提示导致使用的可能性同样较低。当样本不纯的可能性为 0 时,不同条件下的摇头丸使用可能性没有差异。各组之间的摇头丸购买没有差异。无弹性购买与使用潜在不纯摇头丸的可能性更大相关。
总的来说,这些数据突出了教育人们认识到摇头丸中的药理活性而不是惰性掺杂物的必要性,并表明增加毒品检测套件和服务的可及性可能会减轻一些与摇头丸使用相关的危害。